Swedish medtech innovation to make a difference to women worldwide
Gedea Biotech has developed the world’s first antibiotic-free treatment, called pHyph, to both treat and prevent bacterial vaginosis. The treatment is clinically proven to be much safer for women to use, as well as providing a lower risk of recurrence. In addition, Gedea aims to prove that pHyph can treat vulvovaginal candidiasis (VVC) as well.